Literature DB >> 6822660

Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

F Tedesco, P Densen, M A Villa, B H Petersen, G Sirchia.   

Abstract

Restoration of hemolytic activity was examined in sera from seven unrelated eighth component of complement (C8)-deficient subjects. The sera fell into two groups, depending on whether hemolytic activity was restored by the addition of the beta-chain (group 1) or the alpha-gamma-subunit (group 2) purified from normal human C8. Antigenic analysis of these sera by double-immunodiffusion using anti-human C8 confirmed previous findings of a dysfunctional C8 in the four sera of group 1 and established the presence of a different dysfunctional C8 in one of the sera of group 2 when tested at a high concentration. Further characterization of the dysfunctional C8 molecules in the two sera by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated that group 1 sera were missing the beta-subunit and group 2 sera were missing the alpha-gamma-subunit of the C8 molecule. Sera from either of these two groups alone did not produce hemolysis in hemolytic plates containing sheep erythrocytes coated with antibody and complement components up to C7 (EAC1-7) and C9. When sera from the two groups were added to adjacent wells in the hemolytic plates, a zone of hemolysis developed between the wells. The contribution of C8 alpha-gamma from the sera of group 1 and of C8 beta from those of group 2 to the lysis of EAC1-7 in the presence of C9 was confirmed by the inhibitory effect of specific antibodies against the two C8 subunits. In experiments in which hemolytic activity was reconstituted by mixing sera from group 1 with sera from group 2, the serum source of C8 beta (group 2) was the limiting reagent. The dysfunctional C8 molecule in this serum was able to bind to EAC1-7. Chromatographic analysis demonstrated that the generation of hemolytic activity in the mixture of the two sera resulted from the reconstitution of the C8 molecule rather than the sequential action of the two C8 subunits.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822660      PMCID: PMC436856          DOI: 10.1172/jci110758

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  C8 deficiency in a family with xeroderma pigmentosum. Lack of linkage to the HLA region.

Authors:  G Giraldo; L Degos; E Beth; M Sasportes; A Marcelli; R Gharbi; N K Day
Journal:  Clin Immunol Immunopathol       Date:  1977-11

2.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

Authors:  P J Lachmann
Journal:  Immunochemistry       Date:  1971-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.

Authors:  S Bhakdi; J Tranum-Jensen; O Klump
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

6.  A familial dysfunction of the eight component of complement (C8).

Authors:  F Tedesco; M Bardare; A M Giovanetti; G Sirchia
Journal:  Clin Immunol Immunopathol       Date:  1980-06

7.  Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors:  B H Petersen; J A Graham; G F Brooks
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

8.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

9.  The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).

Authors:  W P Klob; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

View more
  21 in total

1.  Binding of human and rat CD59 to the terminal complement complexes.

Authors:  T Lehto; B P Morgan; S Meri
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  DNA polymorphism of the human complement C8 beta gene: formal genetics and intragenic localization.

Authors:  D Herrmann; J M Sodetz; C Rittner; P M Schneider
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits.

Authors:  A Abraha; B P Morgan; J P Luzio
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

4.  Genetic polymorphism of human complement component C81 in the Japanese population.

Authors:  S Nakamura; O Ohue; K Abe
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

5.  Complement induces a transient increase in membrane permeability in unlysed erythrocytes.

Authors:  J A Halperin; A Nicholson-Weller; C Brugnara; D C Tosteson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

6.  Genetic polymorphism of complement component C8.

Authors:  S Rogde; B Mevåg; P Teisberg; T Gedde-Dahl; F Tedesco; B Olaisen
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

7.  Kinetics of assembly and decay of complement components on Escherichia coli O111:B4 preparation of stable intermediates.

Authors:  G Rottini; F Tedesco; M Basaglia; L Roncelli; P Patriarca
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes.

Authors:  J A Halperin; C Brugnara; A Nicholson-Weller
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  The human complement component C8B gene: structure and phylogenetic relationship.

Authors:  T Kaufmann; C Rittner; P M Schneider
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

10.  Genetic polymorphism in C8 beta-chains. Evidence for two unlinked genetic loci for the eighth component of human complement (C8).

Authors:  C A Alper; D Marcus; D Raum; B H Petersen; T J Spira
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.